1 global trends in chemical industry conference delivering the hlg results in the regions 16-17...
TRANSCRIPT
1
Global trends in chemical industryGlobal trends in chemical industry Conference Conference ““Delivering the HLG results in the regions” Delivering the HLG results in the regions” 16-17 April 2009, Usti16-17 April 2009, Usti
ReRenéné van Sloten, Cefic van Sloten, Cefic
2
Key facts and figures
EU is a leading chemicals production platform: 29.5% of world chemicals production (2007)
Around 29,000 companies (96 % have less than 250 employees)
Direct employment of nearly 1.2 millionpeople (2007)
Indirect employment 2.4 million people
Sales of € 537 billion in 2007
Trade surplus of € 35.4 billion in 2007
Note: None of the above figures includes the pharmaceuticals.
3
The main characteristics of the chemical industry strongly influence its competitiveness
The chemical industry has some unique characteristics which have to be taken into account in a competitiveness analysis
Globalised industry
Innovation-driven and knowledge-intensive
Integrated along the value chain into its downstream industries, or directly to consumers
Capital-intensive
Energy intensive
Long product development time, requiring stable and predictable policy framework
4
Chemicals are a truly globalised industry in which competition takes place at a global level
Markets are booming around the world, with average growth rates p.a. of trade and production of up to 25% in certain countries
More than 45% of the value of the global chemical industry is traded. Over 35% of this world trade is intra-company in nature.
Production value growth chemicals excl pharma p.a. 2000 - 2006
Total trade growth chemicals excl pharma p.a. 2000 - 2006
Source: CEFIC, COMTRADE and BASF
5
Global competition in the chemical industry is beneficial, if everybody competes on equal and fair terms
Competition in the chemical industry takes place on all levels: Trade – from and to Europe Investment - building up a presence sales and
production
High growth markets are mainly in non – OECD countries
But growth in other parts of the world is not a zero sum game, as long as any player can benefit from it
Access to markets and a global level playing field are prerequisites for fair and beneficial competition
6
Labour Costs – high but competitive
Labour costs in the EU chemical industry are high.
There are large differences within Europe.
Adjusted by productivity, ULC levels in the EU are competitive with most countries.
Asian countries have lower ULC. This is a comparative advantage.
A strong Euro harms labour cost competitiveness of the EU chemical industry.
0
20
40
60
80
100
120
140
ULC Levels (manufacturing, 2003)In
dex
US
A =
100
Japan USAEU 27 BrazilEastern Europe KoreaChina
Source: “Unit Labor Costs, Productivity and International Competitiveness”, RuG 2005
Exchange Rate2003: 1.13 US$/Euro2007: 1.37 US$/Euro (+20%)
7
Gas prices give a clear advantage to Russia and Middle East
Expensive and scarce goods in Europe, as Europe is neither a strong gas nor oil producer country and has to import its raw materials.
Europe has a good infrastructure, but inputs have to be sourced from other countries.
Security of supply is crucial for a competitive European chemical industry.
Other countries have preferential access to these energy sources. Prices are lower than in Europe and additionally unfair commercial practices take place (e.g. double pricing).
8
Electricity prices in Europe have gone up in recent years
9
Capacity Changes and Closures due to lack of access to renwable feedstock at world market prices
Closing Down of Production Units in Europe
New and/or Extended Capacities Outside Europe
(by Foreign Based Companies and by European Producers)
Germany: Vitamins (Roche; BASF) and Insulin (Pfizer)
UK: Citric Acid (Tate & Lyle), Astaxanthin (Tate & Lyle), Penicillin (ACS Dobfar Ltd) and Xantham Gum (CP Kelco)
Spain: Glutamate (Peniberica) and Lactic Acid (Purac)
Italy: Glutamate (Biacor), Citric Acid (Palcitric; Biacor) and Lysine (Ajinomoto)
Czech Republic: Citric Acid (Activa)France: Yeast (DSM) and Xanthan (Danisco)Portugal: Yeast (DSM) and Penicillin (DSM)The Netherlands: Penicillin (DSM), Gluconic Acid &
Gluconic Derivatives (Purac) and Lactic Acid (Purac)
Ireland: Citric Acid (ADM)
USA: Lactic Acid (CSM/Cargill; Cargill/Dow), Enzymes (Novozymes), Lysine (Cargill/Degussa) and Arachadonic Acid (DSM)
Canada: Citric Acid (Jungbunzlauer)China: Lactic Acid (BBCA, Henan Jindan and
Galactic), Enzymes (Novozymes), Penicillin (DSM), Lysine (Global Biotech, BBCA and others), Citric Acid (DSM, BBCA, TTCA, RZBC, Ensign), Glutamate (Meihua, Fufeng, Juhua, Global Biotech over 500 KT new capacities… ), Xanthan Gum (Fufeng, GCC Inc), Vitamins
Brazil: Enzymes (Novozymes), Lysine (Ajinomoto), Citric Acid (Cargill) and Lactic Acid (Purac)
Mexico & India: Penicillin (DSM)Chile, South-Africa & Cuba: Yeast (DSM)Thailand: Lactic Acid (Purac) and Citric AcidVietnam: Glutamate and Lysine (Vedan and
Ajinomoto)
These changes and closures took place over the last five years.This list is not exhaustive and other examples can be found.
10
Tariffs on bio ethanol are between 30 % and 60 % (10,2 and 19,2 €/hl)
EU demand for bio ethanol has been rising since it is being mixed with fuel for reasons of climate protection (10 % of energetic content of transport fuel has to be derived from plants by 2020)
National and EU regulations set wrong incentives in the utilization of bio ethanol
The EU will not be able to fulfil domestic demand with domestic production
Bio ethanol in Europe is more expensive than the world market price
Other countries have lower import tariffs on bio ethanol for industrial utilization which means a loss of competitiveness for EU chemical industry (e.g. USA)
Access to Raw MaterialsExample Bio ethanol for industrial use
11
Distortion of the APIs Level Playing Field
Factors distorting the API level playing field, causing a landslide, and pushing EU companies out of business
Our home market: The EU• Massive importation of low-priced Rogue APIs (= Counterfeit APIs and APIs
otherwise deliberately and severely non-compliant with pharmaceutical regulations)
Worldwide Markets including EU• Export Subsidies (Exports from India, China…)• Dumping (Chinese APIs & Intermediates)• Slashing VAT Rebate of upstream intermediates / raw materials for APIs• Export Taxes on upstream intermediates / raw materials for APIs• … plus the “given factors” such as currency rates and low wages…
(Exporting to) the Asian Market • Discriminating quality requirements for imported APIs vs.. Locally produced
APIs (China)• Astronomical fees for analytical testing of APIs by Chinese customs• Excessive duplicate testing by Chinese customs: Huge fees multiplicated• Negative lists of APIs that are not allowed to be imported (India)• Import duties (vs. Zero Tariff for API Imports into EU)
12
Trade flows indicate an eroding competitiveness of the EU chemicals industry
13
Trade flows show a competitive position at risk for 50% of the countries (or sectors) analysed
EU has a trade deficit and its competitive position weakened
EU has a trade deficit but its weak competitive position improved
EU has a trade surplus but its positive
competitive position weakened
EU has a trade surplus and its healthy competitive position improved
Japan9%
Rest of Asia15%
Russia8%
USA42%
China8%
South Korea3%
Middle East9%
Brazil3% India
3%
Polymers14%
Organics40%
Basic Inorganics
11%
Consumer Chemicals
12%
Specialities23%
14
Strengths and opportunities for the European chemical industry
Large integrated domestic market with strong customer industry cluster and reasonable demand growth from industry 2.0 % p.a.
Continued strategic restructuring efforts to adapt flexibly to globalised markets
High international orientation and global network to external customer industries
Until now availability of skilled and motivated workers and scientists
Strong innovation efforts will generate new growth clusters: Biotechnology, Renewable feedstock, Efficient Energy use, health and new materials (e.g. nanomaterials) which have the capability to solve upcoming societal mega challenges
15
Weaknesses and threats for the European chemical industry
Diminishing growth stimulus from external demand due to weaker growth prospects for exports to overseas and much stronger import penetration from polymers and specialities.
EU has a comparative price and feedstock disadvantage in Olefins and its derivatives and is facing an upcoming wave of petrochemical capacity additions, especially in ME.
Subdued potential macro growth prospects due to elderly population, shrinking working age classes, high saturation levels.
Energy markets have a “quasi” oligopolistic organisation with much too high energy cost for consumers and industry
16
Long term outlook for the European chemical industry
• Innovation capacity
• Rising demand
• Strong internal market
• New competitors, eg Asia and China
• Macro economic climate
• Energy cost
Access to international markets
Energy policy taking into account the needs of EII
Regulatory burden and uncertainty
New challenges in the area of climate change,
energy, health…
?
PositiveNegative
Challenges
17
Summary competitiveness analysis
Global competition is increasing as regards trade and production locations. Europe’s overall competitiveness is good and the European chemical industry has considerable strengths, but other countries are catching up quickly
A detailed trade analysis already shows an eroding competitive position in some sectors and vis-à-vis certain countries
Provided there are the right framework conditions and the right trade policy, Europe can remain an attractive platform for a competitive chemical industry and benefit from growth markets around the world. A balanced regulatory framework in EuropeFree access to growing marketsFair competition as a stimulator for further growthA global level playing field